Voyager Therapeutics is trading 6.69% higher at $2.86, with no clear catalyst identified for the after-hours move.

  • Shares closed at $2.68 on September 25, 2026, after falling 4.29% during the regular session.
  • The company’s latest listed announcement, dated September 1, concerned upcoming investor conferences; it does not explain the move.
  • Major U.S. indices rose during the session, but that does not establish the reason for the after-hours gain.